Are the renal haemodynamic and natriuretic effects of calcium antagonists and angiotensin converting inhibitors additive?
Natov
S
S
Department of Nephrology, Necker Hospital, Paris, France.
Hannedouche
T
T
Schmitt
F
F
Ikeni
A
A
Déchaux
M
M
Kirkisseli
S
S
Lacour
B
B
Grünfeld
J P
JP
D000328:Adult; D000450:Aldosterone / Q000097:blood; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D001783:Blood Flow Velocity / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D004311:Double-Blind Method; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004656:Enalapril / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D009318:Natriuresis / Q000187:drug effects*; D009529:Nicardipine / Q000008:administration & dosage*; D012079:Renal Circulation / Q000187:drug effects*; D012083:Renin / Q000097:blood; D014655:Vascular Resistance / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D000450:Aldosterone; D004656:Enalapril; C052555:spirapril; D009529:Nicardipine; D012083:Renin